With today's climate for program savings and the growing scrutiny of public healthcare, limited annual and infrequent review of pharmacy program data is not going to be enough to satisfy adequate oversight.

Increased concern over appropriate utilization of high cost specialty medications or abused drugs requires increased scrutiny. In addition, the financial complexity of understanding the true performance of pharmacy outcomes versus costs is also required by the public sector.

Market best-practice: Ongoing oversight
PSRx Advisors provides unique insider developed, auditing capabilities designed to provide the public sector with up-to-daily independent auditing and reporting.

Why so frequent?

• Inappropriate utilization creates an "annuity" obligation to your program that is very difficult to undo.
• Incorrect Prior Authorizations and Fraud-based activity increases your exposure.
• The costs and financials are very complex and tough to reconcile.

PSRx's systems and reporting tools are calibrated for easy to understand performance reports. Variances to expected activity can be shared, researched and corrected by the appropriate stakeholders.

How good are these reports and guidance?
The oversight reports are created by pharmacy benefit program insiders. Our deep-domain experience has enabled PSRx to create data tools and applications that provide relevant pharmacy program performance detail on a frequent basis. We created these reports to assess the areas of the greatest program vulnerabilities and highest return on investment.